logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Parkinsonian Disorders

    FiltersReset Filters
    11 results

    • amantadine

      (amantadine)
      Alembic Pharmaceuticals Inc.
      Usage: Amantadine hydrochloride capsules are indicated for prophylaxis and treatment of influenza A virus infections and for treating parkinsonism and drug-induced extrapyramidal reactions. They are recommended during influenza outbreaks and in patients exhibiting parkinsonism symptoms, although they are less effective than some other treatments for Parkinson's disease.

    • benztropine mesylate

      (BENZTROPINE MESYLATE)
      QUAGEN PHARMACEUTICALS LLC
      Usage: This drug is indicated as an adjunct therapy for all forms of parkinsonism and is also useful in controlling extrapyramidal disorders caused by neuroleptic drugs, excluding tardive dyskinesia.

    • benztropine mesylate

      (BENZTROPINE MESYLATE)
      Fresenius Kabi USA, LLC
      Usage: This drug is indicated as an adjunct therapy for all forms of parkinsonism and is also effective in controlling extrapyramidal disorders caused by neuroleptic drugs, excluding tardive dyskinesia.

    • benztropine mesylate

      (Benztropine Mesylate)
      ScieGen Pharmaceuticals Inc
      Usage: Benztropine mesylate is indicated as an adjunct treatment for all forms of parkinsonism and for controlling extrapyramidal disorders (excluding tardive dyskinesia) caused by neuroleptic medications such as phenothiazines.

    • diphenhydramine

      (Diphenhydramine Hydrochloride)
      Micro Labs Limited
      Usage: Diphenhydramine hydrochloride injectable is indicated for adults and pediatric patients to manage allergic reactions, aid in anaphylaxis as an adjunct to epinephrine, treat motion sickness, and address parkinsonism when oral administration is impractical or contraindicated. Not for use in premature infants or neonates.

    • diphenhydramine

      (DIPHENHYDRAMINE HYDROCHLORIDE)
      Fresenius Kabi USA, LLC
      Usage: This drug is indicated for treating parkinsonism when oral therapy is not feasible, particularly in elderly patients intolerant to stronger agents, mild cases in other age groups, and in conjunction with centrally acting anticholinergic agents.

    • diphenhydramine hydrochloride

      (diphenhydramine hydrochloride)
      Mylan Institutional LLC
      Usage: Diphenhydramine hydrochloride injection is indicated for allergic reactions, anaphylaxis (with epinephrine), motion sickness, and parkinsonism in cases where oral administration is impractical. It is effective for adults and pediatric patients, excluding premature infants and neonates.

    • fluorodopa

      (Fluorodopa F18)
      THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
      Usage: Fluorodopa F 18 Injection is indicated for positron emission tomography (PET) to visualize dopaminergic nerve terminals in the striatum, assisting in the evaluation of adult patients with suspected Parkinsonian syndromes. It serves as an adjunct to other diagnostic evaluations.

    • fluorodopa

      (Fluorodopa F18)
      THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
      Usage: Fluorodopa F 18 Injection is indicated for positron emission tomography (PET) to visualize dopaminergic nerve terminals in the striatum, aiding in the evaluation of adult patients suspected of having Parkinsonian syndromes. It serves as an adjunct to other diagnostic evaluations.

    • ioflupane i 123

      (IOFLUPANE I-123)
      Curium US LLC
      Usage: Ioflupane I 123 Injection is indicated as an adjunct for striatal dopamine transporter visualization via SPECT brain imaging in adults suspected of having Parkinsonian syndromes or dementia with Lewy bodies.